Sample collection and processing techniques play a crucial role in ensuring that research results represent the complete microbiome.
Westbury, NY – BioIVT, a leading provider of research models and services for drug development, today announced that it is hosting a webinar entitled “The Microbiome: Understanding Why Collection and Processing Matters” at 11 a.m. ET on July 25.
The human microbiome is comprised of all the microorganisms – whether beneficial, neutral or harmful – found in or on the human body.
“Since the Human Microbiome Project was launched in 2007, scientific knowledge and understanding of the human microbiome’s role in health and disease have grown dramatically. An individual’s microbiome is now known to impact their overall health, disease severity, and response to medications. In fact, a person’s microbiome is thought to be able to control their pathogens, immune system and mood!” said Mark Driscoll, PhD, Shoreline Biome co-founder.
“As we learn more about the potent impact that an individual’s microbiome can have on their overall health, the desire to harness it to improve health outcomes increases,” said Cathie G. Miller, PhD, BioIVT director of product marketing, personalized medicine. “To optimize microbiome research, scientists need access to high quality disease-state and control samples, which have been collected and processed using standardized, highly reproducible techniques. That is one of BioIVT’s areas of expertise.”
This webinar, which will be co-presented by Drs. Driscoll and Miller, will discuss best practices for securing representative samples of all microbes within a biospecimen.
Drs. Driscoll and Miller will outline optimal sample collection, processing and assay techniques. They will also discuss the importance of sample lysis and primer design and how to select the most appropriate sequencing platform and database mapping approach. In addition, they will review a case study with webinar attendees.
BioIVT has the largest network of IRB-approved sample collection sites in the industry, together with an extensive inventory of the highest quality disease-state and control biospecimens. Samples are available for a wide range of conditions, including Crohn’s disease, ulcerative colitis, irritable bowel disease, celiac disease, functional abdominal pain syndrome, and diarrhea. Furthermore, BioIVT works closely with its clients and has the ability to customize all aspects of its sample collection and storage processes.
Interested parties can register for this complimentary one-hour webinar at http://info.bioivt.com/microbiome-collection-webinar-registration.
BioIVT, formerly BioreclamationIVT, is a leading global provider of research models and value-added research services for drug discovery and development. We specialize in control and disease-state biospecimens including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. Our PHASEZERO® Research Services team works collaboratively with clients to provide target and biomarker validation, phenotypic assays to characterize novel therapeutics, clinical assay development and in vitro hepatic modeling solutions. And as the premier supplier of ADME-toxicology model systems, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly-discovered compounds and their effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in elevating science. For more information, please visit www.bioivt.com or follow the company on Twitter @BioIVT.
BioIVT Contact: Courtney Noah, Vice President of Marketing, 516-483-1196
Media Contact: Lisa Osborne, Rana Healthcare Solutions, 206-992-5245, email@example.com